Commercial Channels

New study finds a growing reliance on patient organizations for improving the patient journey

RACollab.org invites trade and channel execs to participate

Deep analysis of specialty pharmacy data shows opportunities for managing the patient journey

Emphasis is on speed to therapy

Pharmacy-level patient identification could have implications for pharma manufacturers

Appointment highlights the trend toward digital patient services

Patient support/hub services provider will build in Jeffersonville, IN

Meanwhile, federal enforcement actions over improper patient assistance continue to arise

Kalderos garners $7-million Series A funding from Mercato Partners

Latest acquisition brings commercial assets from Mission Pharmacal

Business opportunities expand, include selling healthcare data to researchers

Managed Retail Network will offer “light” patient support services through 25,000 pharmacies

Mobile apps promise to expand hub support for specialty pharmaceuticals

The Unstoppable Growth of Prescription Drug Prices

A final rule is still in the works at HHS, but some manufacturers are testing the inclusion of prices in TV ads

It takes gritty work to make an AI application succeed—but it can be worth the effort

The head of Lash Group looks at the evolving patient support / hub services environment

Hub provider and software company will partner for advancing cellular and genetic therapies (CGTs)

Model N positions itself for coming revisions in pharma trade practices

The longstanding adherence problem is yielding to new technology

A changing role for hubs in collecting critical data, raising adherence

The goal of producing meaningful data is driving industry progress

By working with the sales force, incentive plan design can boost a product launch

Diligent Health Solutions banks on experienced management

A marketing challenge: how to make more adults aware of anti-bacterial booster shots

Signs up Bayer Health for pulmonary hypertension and MS

Programs provide copay and other financial assistance

Spending on drug promotion rose—but not at the rate of pharma sales growth

Sandoz and Pear Therapeutics tackle opioid use disorder